| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 02/07/2007 | CN1907982A New compounds useful for the treatment of obesity,type II diabetes and CNS disorders |
| 02/07/2007 | CN1298703C Cyanopyrolidine derivatives |
| 02/07/2007 | CN1298702C Process for preparing (s)-1-allyl-2-amidomethyl tetrahydropyrrole |
| 02/07/2007 | CN1298321C Use of phototoxicity control object of preparing medicine for restraining phototoxicity by ultraviolet radiation |
| 02/06/2007 | US7173139 Enantioselective 1,4-addition of aromatic nucleophiles to α,β-unsaturated aldehydes using chiral organic catalysts |
| 02/06/2007 | US7173132 Certain substituted 1-aryl-3-piperazine-1′-yl propanones |
| 02/06/2007 | US7173059 Optically active 3-amino-butene and 1,2-dihydroxy-3-amino-butane intermediate compounds |
| 02/06/2007 | US7173024 Compounds having prolyl oligopeptidase inhibitory activity, methods for their preparation and their use |
| 02/01/2007 | WO2007013694A1 Phenoxyalkanoic acid compound |
| 02/01/2007 | WO2007012849A2 MASS LABELS FOR BIOMOLECULES CONTAINING A 2,6-DIMETHYL-PIPERIDIN-l-YL METHYLENE OR A PYRIMIDIN-2-YL THIOMETHYLENE MASS MARKER MOIETY AND A SUCCINIMID-OXY-CARBONYL REACTIVE FUNCTIONAL GROUP |
| 02/01/2007 | WO2006108689A3 Process for preparing bicyclic compounds |
| 02/01/2007 | US20070027328 Processes for desolvating solvates of atorvastatin hemi-calcium and atorvastatin hem-calcium essentially free of organic solvent |
| 02/01/2007 | US20070027326 Process for the manufacture of an enantiopure compound |
| 02/01/2007 | US20070027201 Use of progesterone receptor modulators |
| 02/01/2007 | US20070027158 High affinity small molecule C5a receptor modulators |
| 02/01/2007 | US20070027126 E.g., N-[4-(5-cyano-1-methyl-1H-pyrrol-2-yl)phenyl]propane-1-sulfonamide and tert-butyl 2-cyano-5-{4-{(ethylsulfonyl)amino]phenyl}-1H-pyrrole-1-carboxylate; useful for contraception and hormone replacement therapy |
| 02/01/2007 | US20070027125 Cyanopyrrole-phenyl progesterone receptor modulators and uses thereof |
| 02/01/2007 | US20070023628 Labeling agents for mass spectrometry comprising tertiary amines |
| 02/01/2007 | CA2616985A1 Mass labels for biomolecules containing a 2,6-dimethyl-piperidin-i-yl methylene or a pyrimidin-2yl thiomethylene mass marker moiety and a succinimid-oxy-carbonyl reactive functional group |
| 01/31/2007 | EP1747210A1 3- or 4-monosubstituted phenol and thiophenol derivatives useful as h3 ligands |
| 01/31/2007 | EP1747199A1 Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 01/31/2007 | EP1747198A1 Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 01/31/2007 | EP1747193A1 Benzonitrile derivatives to treat musculoskeletal frailty |
| 01/31/2007 | CN1906183A N-acylsulfonamide apoptosis promoters |
| 01/31/2007 | CN1906181A N-sulfonylaminocarbonyl containing compounds |
| 01/31/2007 | CN1906161A N-sulfonyldicarboximide containing tethering compounds |
| 01/31/2007 | CN1906160A Imidazole derivatives, processes for preparing them and their uses |
| 01/31/2007 | CN1905868A DPP-IV inhibitors |
| 01/31/2007 | CN1905793A 2-ethyl-4,6-dimethyl-phenyl-substituted tetramic acid derivatives as pest control agents and/or herbicides |
| 01/31/2007 | CN1297539C Process for the manufacture of amino-pyrrolidine derivatives |
| 01/31/2007 | CN1297535C Method for producing perfluoroalkane sulfonic acid esters and the salts thereof |
| 01/30/2007 | US7169937 use for regulating the degree of polymerization during the polymerization of monomers, such as homo- or copolymerization of chloroprene and/or dichlorobutadiene |
| 01/30/2007 | US7169933 Immobilization of compounds with connector groups of amines |
| 01/30/2007 | US7169932 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis |
| 01/30/2007 | US7169928 central nervous system disorders; Alzheimer's disease; attention deficit disorders; cognition activators; psychological disorders; antidepressants |
| 01/30/2007 | US7169829 Maleimido-bearing compounds resin composition containing the same and cured articles thereof |
| 01/30/2007 | US7169806 Antidiabetic agents |
| 01/30/2007 | US7169805 Captopril derivatives |
| 01/30/2007 | US7169804 Bactericides; veterinary medicine |
| 01/30/2007 | US7169795 For use as anticoagulant agents for therapy of thromboembolic disorders |
| 01/30/2007 | US7169558 Using non-radioactive markers to identify nascent proteins translated within cellular or cell-free translation systems; bioremediation and pollution contol of biohazards |
| 01/30/2007 | CA2307551C Pleuromutilin derivatives as antimicrobials |
| 01/30/2007 | CA2260060C Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents |
| 01/30/2007 | CA2228939C Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 01/30/2007 | CA2226886C N-(4-substituted-benzyl)-2-aminolactam derivatives |
| 01/30/2007 | CA2163747C Novel 1-phenylalkanone 5-ht4 receptor ligands |
| 01/25/2007 | WO2007011162A1 Synthetic method of optically pure (s)-3-hydroxypyrrolidine |
| 01/25/2007 | WO2007010266A1 Pyrrolidine compositions |
| 01/25/2007 | WO2007010222A2 Therapeutic agents |
| 01/25/2007 | WO2007009904A1 Catalyst with bimodal distribution of the particles of the catalytically active material, method for the production thereof and for the regeneration thereof and the use of the catalyst |
| 01/25/2007 | WO2007009354A1 Pyrrolidine derivative intermediates,preparation and usage thereof |
| 01/25/2007 | WO2007009299A1 Optically pure n',n'-di substituted -prolylhydrazines as well as the preparation and use thereof |
| 01/25/2007 | WO2006131303A3 Peptide deformylase (pdf) inhibitors 4 |
| 01/25/2007 | WO2006122408A9 Bir domain binding compounds |
| 01/25/2007 | WO2006086358A3 Mitotic kinesin inhibitors |
| 01/25/2007 | US20070021606 Therapeutic compounds |
| 01/25/2007 | US20070021604 To be used as acidic catalysts |
| 01/25/2007 | US20070021494 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 01/25/2007 | US20070021484 Substituted N-cinnamyl benzamides |
| 01/25/2007 | US20070021464 Methods and compositions for inhibition of angiogenesis with EM-12 Derivatives |
| 01/25/2007 | US20070021424 e.g. 2-(methylamino)-2-oxoethyl {2-[(4-chlorophenyl)-oxy]ethyl}carbamate; fatty acid amide hydrolase inhibitor; cannabinoid and vanilloid receptors blocking agent; analgesic, antiinflammatory, anticarcinogenic, anxiolytic agent, neurodegenerative diseases, antidepressant |
| 01/25/2007 | US20070021405 Aryl- and heteroarylpiperidinecarboxylate-derivatives methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/25/2007 | US20070021404 Novel aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/25/2007 | US20070021403 Piperidinylalkylcarbamate derivatives, methods for their preparation and the therapeutic use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/25/2007 | US20070021381 Stabilizing the mutant enzyme by administering a reversible competitive inhibitor consisting an iminosugar, 4-epi-isofagomine or 1-deoxygalactonojirimycin; Gaucher's disease; lysosomal storage diseases |
| 01/25/2007 | US20070021354 Viricides; immunomoderator; mixture with other Aids drugs |
| 01/25/2007 | US20070020643 High affinity for streptavidin/avidin; biotinyl moiety linked to a photoreactive group covalently bound to substrate (proteins, peptides, amino acids, and nucleic acids); Exposure of the conjugate to radiation releases the target in a functional form and completely unaltered |
| 01/24/2007 | EP1746086A1 Cyanopyrrolidine derivatives |
| 01/24/2007 | EP1745525A1 Material for electrolytic solution, ionic material-containing composition and use thereof |
| 01/24/2007 | EP1745048A2 Simple stereocontrolled synthesis of salinosporamide a |
| 01/24/2007 | EP1745037A1 Indolylmaleimide derivatives as pkc inhibitors |
| 01/24/2007 | EP1745032A2 Cxcr1 and cxcr2 chemokine antagonists |
| 01/24/2007 | EP1745020A2 Salt forms of atorvastatin |
| 01/24/2007 | EP1745019A1 Novel compounds of proline and morpholine derivatives |
| 01/24/2007 | EP1745015A1 Bicyclic aromatic sulfinyl derivatives |
| 01/24/2007 | EP1745003A1 Novel compounds, their preparation and use |
| 01/24/2007 | EP1472217B1 Method for producing perfluoroalkane sulfonic acid esters and the salts thereof |
| 01/24/2007 | CN1902283A Reagent for detecting an analyte |
| 01/24/2007 | CN1902194A Process for preparing amorphous (4r-cis)-6-[2-[3-phenyl-4-(phenylcarbamoyl)-2-(4-fluorophenyl)-5-(1-methyl)-pyrrol-1-yl]-2,2-dimethyl-[1,3]-dioxane-4-yl-acetic acid |
| 01/24/2007 | CN1902175A Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof |
| 01/24/2007 | CN1902174A Cis-alkoxyspiro-substituted tetramic acid derivatives |
| 01/24/2007 | CN1902173A Vitamin d3 lactam derivative |
| 01/24/2007 | CN1902172A N-acylated-3- (benzoyl) - pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders |
| 01/24/2007 | CN1902171A Benzylether amine compounds useful as CCR-5 antagonists |
| 01/24/2007 | CN1902170A 1,2-di(cyclic) substituted benzene compounds |
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/24/2007 | CN1296354C Pharmaceutically active pyrrolidine derivatives as BAX inhibitors |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/23/2007 | US7166743 Methods of making intermediates from polyhydroxyalkanoates |
| 01/23/2007 | US7166638 Statin derivatives |
| 01/23/2007 | US7166618 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 01/23/2007 | US7166601 A phenylamide derivatives for treating gastrointestinal reflux disorders, eating disorder obesity and irritable bowel disorder |
| 01/23/2007 | US7166593 Glucocorticoid receptor modulators |
| 01/23/2007 | US7166590 Antiischemic agents; cardiovascular disorders |
| 01/18/2007 | WO2007007018A1 Piperazine heteroaryl derivates as gpr38 agonists |
| 01/18/2007 | WO2007006682A1 Phenylazo-acetoacetanilide derivatives with a polymer! zable functional group and related compounds as monomers for preparing polymeric pigment dispersants for inkjet inks |
| 01/18/2007 | WO2006123356B1 Process for the preparation of indolone derivative |
| 01/18/2007 | WO2006102097A3 Synthesis of avrainvillamide, stephacidin b, and analogues thereof |
| 01/18/2007 | WO2006055951A3 Tetrahydroisoquinolines as factor xa inhibitors |
| 01/18/2007 | US20070015924 stereoselective preparation of aminocyclohexyl ether compounds such as trans-(1R,2R)-aminocyclohexyl ether compounds and/or trans-(1S,2S)-aminocyclohexyl ether compounds; useful in treating arrhythmias |